Arch Biopartners Inc
XTSX:ARCH

Watchlist Manager
Arch Biopartners Inc Logo
Arch Biopartners Inc
XTSX:ARCH
Watchlist
Price: 2.03 CAD 1.5%
Market Cap: 131.2m CAD
Have any thoughts about
Arch Biopartners Inc?
Write Note

Net Margin
Arch Biopartners Inc

-137.6%
Current
-119%
Average
-0.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-137.6%
=
Net Income
-6.1m
/
Revenue
4.5m

Net Margin Across Competitors

Country CA
Market Cap 128.5m CAD
Net Margin
-138%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 207.5B USD
Net Margin
14%
Country US
Market Cap 173.4B USD
Net Margin
18%
Country KR
Market Cap 70.2T KRW
Net Margin
24%
Country CH
Market Cap 40.8B CHF
Net Margin
9%
Country US
Market Cap 39.2B USD
Net Margin
9%
Country US
Market Cap 38.5B USD
Net Margin
22%
Country US
Market Cap 26.5B USD
Net Margin
21%
Country US
Market Cap 23.7B USD
Net Margin
-36%
Country US
Market Cap 23.6B USD
Net Margin
17%

Profitability Report

View the profitability report to see the full profitability analysis for Arch Biopartners Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-137.6%
=
Net Income
-6.1m
/
Revenue
4.5m
What is the Net Margin of Arch Biopartners Inc?

Based on Arch Biopartners Inc's most recent financial statements, the company has Net Margin of -137.6%.